{"id":30711,"date":"2025-03-27T14:37:46","date_gmt":"2025-03-27T06:37:46","guid":{"rendered":"https:\/\/flcube.com\/?p=30711"},"modified":"2025-03-27T14:37:48","modified_gmt":"2025-03-27T06:37:48","slug":"insilico-medicine-collaborates-with-mabwell-bio-to-enhance-adc-rd-with-ai","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=30711","title":{"rendered":"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI"},"content":{"rendered":"\n

China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062<\/a>) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields, though financial specifics of the deal were not disclosed.<\/p>\n\n\n\n

Technical Synergy<\/strong>
Mabwell Bio brings to the table comprehensive platform technology and a wealth of R&D data accumulated across the entire ADC industry chain. This enables the development of innovative ADCs with uniform structure, stable quality, and clinical validation. Insilico Medicine, on the other hand, touts its Pharma.AI, an integrated drug development platform that spans biology, chemistry, clinical medicine, and scientific research. Alongside PandaOmics, Generative Biologics, and other engines, Insilico aims to enhance R&D efficiency by empowering drug target identification and the de novo generation of molecular fragments.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot…<\/p>\n","protected":false},"author":1,"featured_media":30712,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[35,99,164,118,1129],"class_list":["post-30711","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-adc-xdc","tag-ai","tag-insilico-medicine","tag-mabwell-bioscience","tag-sha-688062"],"yoast_head":"\nInsilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields, though financial specifics of the deal were not disclosed.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=30711\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI\" \/>\n<meta property=\"og:description\" content=\"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields, though financial specifics of the deal were not disclosed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=30711\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-27T06:37:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-27T06:37:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2706-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI\",\"datePublished\":\"2025-03-27T06:37:46+00:00\",\"dateModified\":\"2025-03-27T06:37:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711\"},\"wordCount\":175,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2706-png.webp\",\"keywords\":[\"ADC \\\/ XDC\",\"AI\",\"Insilico Medicine\",\"Mabwell Bioscience\",\"SHA: 688062\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30711#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=30711\",\"name\":\"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2706-png.webp\",\"datePublished\":\"2025-03-27T06:37:46+00:00\",\"dateModified\":\"2025-03-27T06:37:48+00:00\",\"description\":\"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields, though financial specifics of the deal were not disclosed.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=30711\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2706-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2706-png.webp\",\"width\":1080,\"height\":608,\"caption\":\"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=30711#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI - Insight, China's Pharmaceutical Industry","description":"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields, though financial specifics of the deal were not disclosed.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=30711","og_locale":"en_US","og_type":"article","og_title":"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI","og_description":"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields, though financial specifics of the deal were not disclosed.","og_url":"https:\/\/flcube.com\/?p=30711","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-27T06:37:46+00:00","article_modified_time":"2025-03-27T06:37:48+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2706-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=30711#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=30711"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI","datePublished":"2025-03-27T06:37:46+00:00","dateModified":"2025-03-27T06:37:48+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=30711"},"wordCount":175,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=30711#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2706-png.webp","keywords":["ADC \/ XDC","AI","Insilico Medicine","Mabwell Bioscience","SHA: 688062"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=30711#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=30711","url":"https:\/\/flcube.com\/?p=30711","name":"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=30711#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=30711#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2706-png.webp","datePublished":"2025-03-27T06:37:46+00:00","dateModified":"2025-03-27T06:37:48+00:00","description":"China's generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields, though financial specifics of the deal were not disclosed.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=30711#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=30711"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=30711#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2706-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2706-png.webp","width":1080,"height":608,"caption":"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=30711#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/2706-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30711"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30711\/revisions"}],"predecessor-version":[{"id":30713,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/30711\/revisions\/30713"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/30712"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}